Karus Therapeutics Appoints Dr Stephen Shuttleworth as Chairman of Scientific Advisory Board

ANNOUNCEMENT Oxfordshire, UK, 17 September 2019 – Karus Therapeutics Ltd (‘Karus’), a clinical-stage biopharmaceutical company developing precision medicines for cancer, today announced that Dr Stephen Shuttleworth will become Chairman of its Scientific Advisory Board with immediate effect. After almost 12 years with Karus, the Company’s Founding Scientist and CSO (and latterly joint COO/CSO) and Executive […]